U2AF1 and myelodysplastic syndrome: According to the cBioPortal database [47,48] reporting of 4 studies of adult MDS and AML patients [4,49–51], U2AF1 mutations occur in 5% and NPM1 is mutated in 22% of all myeloid malignancy patients.